III.7. Irodalomjegyzék

  1. Antzelevitch C. Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes. Heart Rhythm. 2005; 2(2 Suppl): S9-15.
  2. Baczkó I, Orosz A, Lengyel Cs, Varró A. Athletic heart: the possible role of impaired repolarization reserve in development of sudden cardiac death. Athlete performance and injuries (Eds: Bastos JH, Silva AC), Nova Science Publishers Inc., 2012; 123-143.
  3. Csáky  I,  Fekete  S. Soybean:  feed  quality  and  safety.  Part  1:  biologically active components. A review. Acta Vet Hung 2004; 52: 299-313.
  4. Fazekas T. A hosszú-QT-szindróma és a torsades de pointes kamrai tachycardia története. Kaleidoscope. Művelődés-, Tudomány- és Orvostörténeti Folyóirat. 2012; 3(5): 23-70.
  5. Fazekas T, Kiss Z. Kamrai tachycardia "torsade de pointe" jelenséggel. Magy Belorv Arch. 1979; 32: 199-204.
  6. Fazekas T, Krassói I, Lengyel C, Varró A, Papp JG. Suppression of erythromycin-induced early afterdepolarizations and torsade de pointes ventricular tachycardia by mexiletine. Pacing Clin Electrophysiol. 1998; 21(1 Pt 2): 147-150.
  7. Fazekas T, Liszkai G: Ventricular proarrhythmias induced by antiarrhythmic drugs, non-cardiovascular agents, and implantable antiarrhythmia devices. Prog Biomed Res 2001; 5: 391-396.
  8. Jost N, Virág L, Bitay M, Takács J, Lengyel Cs, Biliczki P., et al. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle. Circulation 2005; 112: 1392-1399.
  9. Kristóf A, Husti Z, Koncz I, Kohajda Z, Szél T, Juhász V, et al. Diclofenac prolongs repolarization in ventricular muscle with impaired repolarization reserve. PLoS One. 2012; 7(12): e53255.
  10. Lengyel Cs, Fazekas T. A szerzett hosszú-QT-szindróma és a torsades de pointes kamrai tachycardia. Klinikai szív-elektrofiziológia és aritmológia (Eds: Fazekas T, Merkely B, Papp Gy, Tenczer J), Akadémiai Kiadó, Budapest, 2009; 673-724.
  11. Lengyel C, Orosz A, Hegyi P, Komka Z, Udvardy A, Bosnyák E, et al. Increased short-term variability of the QT interval in professional soccer players: possible implications for arrhythmia prediction. PLoS One. 2011; 6(4): e18751.
  12. Lengyel C, Varró A, Tábori K, Papp JG, Baczkó I. Combined pharmacological block of IKr and IKs increases short-term QT interval variability and provokes torsades de pointes. Br J Pharmacol. 2007; 151(7): 941-51.
  13. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 2001; 22: 1374-1450.
  14. Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, és mtsai. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network metaanalysis. BMJ 2011; 342: c7086.
  15. Varró A, Baczkó I. Possible mechanisms of sudden cardiac death in top athletes: a basic cardiac electrophysiological point of view. Pflug Arch Eur J Physiol 2010; 460: 31-40.
  16. Varró A, Baczkó I. Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk. Br J Pharmacol 2011; 164: 14-36.
  17. Volders PG, Sipido KR, Vos MA, Spätjens RL, Leunissen JD, Carmeliet E, Wellens HJ. Downregulation of delayed rectifier K+ currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes. Circulation 1999; 100: 2455-2461.
  18. Zitron E, Scholz E, Owen RW, Lück S, Kiesecker C, Thomas D, et al. QTc  prolongation  by  grapefruit  juice  and  its  potential  pharmacological  basis.  HERG  channel  blockade  by  flavonoids.  Circulation 2005;111:835-838.